REPORT ID 13811

United States Newcastle Disease Vaccine Market Report 2019

Publish Date
2019
Pages
112
Format
Electronic (PDF)

In this report, the United States Newcastle Disease Vaccine market is valued at USD   XX million in 2019 and is expected to reach USD  XX million by the end of 2025, growing at a CAGR of  XX% between 2019 and 2025.

Geographically, this report splits the United States market into seven regions:
    The West
    Southwest
    The Middle Atlantic
    New England
    The South
    The Midwest
with sales (volume), revenue (value), market share and growth rate of Newcastle Disease Vaccine in these regions, from   2019 to 2025 (forecast).

United States Newcastle Disease Vaccine market competition by top manufacturers/players, with Newcastle Disease Vaccine sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    Merial
    CEVA
    QYH Biotech
    Ringpu Biology
    Yebio
    Harbin Veterinary Research Institute
    Merck Animal Health
    DHN
    Zoetis
    ChengDu Tecbond
    Elanco (Lohmann)
    FATRO
    CAVAC
    Vaksindo

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Live Vaccines
    Killed Vaccines
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Chicken
    Duck & Goose
    Other

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

United States Newcastle Disease Vaccine Market  Report 2019
1 Newcastle Disease Vaccine Overview
    1.1 Product Overview and Scope of Newcastle Disease Vaccine
    1.2 Classification of Newcastle Disease Vaccine by Product Category
        1.2.1 United States Newcastle Disease Vaccine Market Size (Sales Volume) Comparison by Type ( 2014-2024)
        1.2.2 United States Newcastle Disease Vaccine Market Size (Sales Volume) Market Share by Type (Product Category)  in 2018
        1.2.3 Live Vaccines
        1.2.4 Killed Vaccines
    1.3 United States Newcastle Disease Vaccine Market by Application/End Users
        1.3.1 United States Newcastle Disease Vaccine Market Size (Consumption) and Market Share Comparison by Application ( 2014-2024)
        1.3.2 Chicken
        1.3.3 Duck & Goose
        1.3.4 Other
    1.4 United States Newcastle Disease Vaccine Market by Region
        1.4.1 United States Newcastle Disease Vaccine Market Size (Value) Comparison by Region ( 2014-2024)
        1.4.2 The West Newcastle Disease Vaccine Status and Prospect ( 2014-2024)
        1.4.3 Southwest Newcastle Disease Vaccine Status and Prospect ( 2014-2024)
        1.4.4 The Middle Atlantic Newcastle Disease Vaccine Status and Prospect ( 2014-2024)
        1.4.5 New England Newcastle Disease Vaccine Status and Prospect ( 2014-2024)
        1.4.6 The South Newcastle Disease Vaccine Status and Prospect ( 2014-2024)
        1.4.7 The Midwest Newcastle Disease Vaccine Status and Prospect ( 2014-2024)
    1.5 United States Market Size (Value and Volume) of Newcastle Disease Vaccine ( 2014-2024)
        1.5.1 United States Newcastle Disease Vaccine Sales and Growth Rate ( 2014-2024)
        1.5.2 United States Newcastle Disease Vaccine Revenue and Growth Rate ( 2014-2024)

2 United States Newcastle Disease Vaccine Market Competition by Players/Suppliers
    2.1 United States Newcastle Disease Vaccine Sales and Market Share of Key Players/Suppliers ( 2014-2019)
    2.2 United States Newcastle Disease Vaccine Revenue and Share by Players/Suppliers ( 2014-2019)
    2.3 United States Newcastle Disease Vaccine Average Price by Players/Suppliers ( 2014-2019)
    2.4 United States Newcastle Disease Vaccine Market Competitive Situation and Trends
        2.4.1 United States Newcastle Disease Vaccine Market Concentration Rate
        2.4.2 United States Newcastle Disease Vaccine Market Share of Top 3 and Top 5 Players/Suppliers
        2.4.3 Mergers & Acquisitions, Expansion in United States Market
    2.5 United States Players/Suppliers Newcastle Disease Vaccine Manufacturing Base Distribution, Sales Area, Product Type

3 United States Newcastle Disease Vaccine Sales (Volume) and Revenue (Value) by Region ( 2014-2019)
    3.1 United States Newcastle Disease Vaccine Sales and Market Share by Region ( 2014-2019)
    3.2 United States Newcastle Disease Vaccine Revenue and Market Share by Region ( 2014-2019)
    3.3 United States Newcastle Disease Vaccine Price by Region ( 2014-2019)

4 United States Newcastle Disease Vaccine Sales (Volume) and Revenue (Value) by Type (Product Category) ( 2014-2019)
    4.1 United States Newcastle Disease Vaccine Sales and Market Share by Type (Product Category) ( 2014-2019)
    4.2 United States Newcastle Disease Vaccine Revenue and Market Share by Type ( 2014-2019)
    4.3 United States Newcastle Disease Vaccine Price by Type ( 2014-2019)
    4.4 United States Newcastle Disease Vaccine Sales Growth Rate by Type ( 2014-2019)

5 United States Newcastle Disease Vaccine Sales (Volume) by Application ( 2014-2019)
    5.1 United States Newcastle Disease Vaccine Sales and Market Share by Application ( 2014-2019)
    5.2 United States Newcastle Disease Vaccine Sales Growth Rate by Application ( 2014-2019)
    5.3 Market Drivers and Opportunities

6  United States Newcastle Disease Vaccine Players/Suppliers Profiles and Sales Data
    6.1 Merial
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Newcastle Disease Vaccine Product Category, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Merial Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.1.4 Main Business/Business Overview
    6.2 CEVA
        6.2.2 Newcastle Disease Vaccine Product Category, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 CEVA Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.2.4 Main Business/Business Overview
    6.3 QYH Biotech
        6.3.2 Newcastle Disease Vaccine Product Category, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 QYH Biotech Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.3.4 Main Business/Business Overview
    6.4 Ringpu Biology
        6.4.2 Newcastle Disease Vaccine Product Category, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Ringpu Biology Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.4.4 Main Business/Business Overview
    6.5 Yebio
        6.5.2 Newcastle Disease Vaccine Product Category, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Yebio Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.5.4 Main Business/Business Overview
    6.6 Harbin Veterinary Research Institute
        6.6.2 Newcastle Disease Vaccine Product Category, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Harbin Veterinary Research Institute Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.6.4 Main Business/Business Overview
    6.7 Merck Animal Health
        6.7.2 Newcastle Disease Vaccine Product Category, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Merck Animal Health Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.7.4 Main Business/Business Overview
    6.8 DHN
        6.8.2 Newcastle Disease Vaccine Product Category, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 DHN Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.8.4 Main Business/Business Overview
    6.9 Zoetis
        6.9.2 Newcastle Disease Vaccine Product Category, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 Zoetis Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.9.4 Main Business/Business Overview
    6.10 ChengDu Tecbond
        6.10.2 Newcastle Disease Vaccine Product Category, Application and Specification
            6.10.2.1 Product A
            6.10.2.2 Product B
        6.10.3 ChengDu Tecbond Newcastle Disease Vaccine Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.10.4 Main Business/Business Overview
    6.11 Elanco (Lohmann)
    6.12 FATRO
    6.13 CAVAC
    6.14 Vaksindo

7 Newcastle Disease Vaccine Manufacturing Cost Analysis
    7.1 Newcastle Disease Vaccine Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Newcastle Disease Vaccine

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Newcastle Disease Vaccine Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Newcastle Disease Vaccine Major Manufacturers  in 2018
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 United States Newcastle Disease Vaccine Market Size (Value and Volume) Forecast ( 2019-2025)
    11.1 United States Newcastle Disease Vaccine Sales Volume, Revenue Forecast ( 2019-2025)
    11.2 United States Newcastle Disease Vaccine Sales Volume Forecast by Type ( 2019-2025)
    11.3 United States Newcastle Disease Vaccine Sales Volume Forecast by Application ( 2019-2025)
    11.4 United States Newcastle Disease Vaccine Sales Volume Forecast by Region ( 2019-2025)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer